COMMUNIQUÉS West-GlobeNewswire

Osmotica Pharmaceuticals to Present at BMO Capital Markets 2018 Prescriptions for Success Healthcare Conference

03/12/2018 - 22:30

BRIDGEWATER, N.J., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Osmotica Pharmaceuticals plc (“Osmotica” or the “Company”) (Nasdaq: OSMT), a fully integrated biopharmaceutical company, today announced that Brian Markison, Chief [...]

Geron Announces New Overall Survival Data from IMbark in Imetelstat-Treated Patients with Intermediate-2 or High-Risk Myelofibrosis and Relapsed/Refractory to Janus Kinase Inhibitor Therapy

03/12/2018 - 22:22

Data Reporting Median Overall Survival of 29.9 Months in High-Dose Arm Presented at the 60th American Society of Hematology Annual Meeting MENLO PARK, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq [...]

Diversicare Completes Sale of Three Skilled Nursing Facilities in Kentucky

03/12/2018 - 22:20

BRENTWOOD, Tenn., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Diversicare Healthcare Services, Inc. (NASDAQ: DVCR), a premier provider of post-acute care services, today announced that effective December 1, 2018 the Company [...]

Adverum Biotechnologies Appoints Mike Fitzgerald as Vice President, Human Resources

03/12/2018 - 22:10

MENLO PARK, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced [...]

Zogenix Reports Granting of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)

03/12/2018 - 22:05

EMERYVILLE, Calif., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Zogenix, Inc. (Nasdaq: ZGNX), a pharmaceutical company developing therapies for the treatment of rare central nervous system (CNS) disorders, today announced that it [...]

Scholar Rock Announces Positive Opinion by the European Medicines Agency on Orphan Drug Designation for SRK-015 for the Treatment of Spinal Muscular Atrophy

03/12/2018 - 22:05

CAMBRIDGE, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Scholar Rock Holding Corporation (NASDAQ: SRRK), a clinical-stage biopharmaceutical company focused on the treatment of serious diseases in which protein growth [...]

Momenta Pharmaceuticals Provides Update on US Regulatory Strategy for M923, Proposed Biosimilar to HUMIRA®

03/12/2018 - 22:05

CAMBRIDGE, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Momenta Pharmaceuticals, Inc. (Nasdaq: MNTA), a biotechnology company with a validated scientific platform focused on discovering and developing novel therapeutics to [...]

Paratek Pharmaceuticals Files Two Patent Term Extensions in the United States; Expects NUZYRA™ Patent Protection Exclusivity Until at Least October 2030

03/12/2018 - 22:01

BOSTON, Dec. 03, 2018 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc. (Nasdaq: PRTK), a commercial-stage biopharmaceutical company focused on the development and commercialization of innovative therapeutics, today [...]

University Medical Centre Groningen chooses TAT-5000 of Exergen Medical as standard thermometer throughout hospital

03/12/2018 - 21:54

WATERTOWN, Mass. and GRONINGEN, The Netherlands, Dec. 03, 2018 (GLOBE NEWSWIRE) -- University Medical Centre Groningen has decided to standardize on the TAT-5000 thermometer of Exergen Medical. The well-known university [...]

Nextech and Red Spot Interactive Partner to Enhance Provider Retention and Patient Acquisition

03/12/2018 - 21:47

Product integration delivers tools to encourage profit driven business decisions for specialty healthcare practices TAMPA, Fla., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Nextech Systems , a leading provider of healthcare [...]

INNATE PHARMA : Updated results that support advancement of IPH4102 in refractory Sézary syndrome at ASH 2018

03/12/2018 - 20:46

INNATE PHARMA ANNOUNCES UPDATED RESULTS THAT SUPPORT ADVANCEMENT OF IPH4102 IN REFRACTORY SÉZARY SYNDROME AT THE AMERICAN SOCIETY OF HEMATOLOGY (ASH) 2018 ANNUAL MEETING Differentiating profile of IPH4102 confirmed: [...]

INNATE PHARMA : ASH, présentation de résultats d'IPH4102 chez les patients présentant un syndrome de Sézary réfractaire et poursuite du développement en phase II dans les lymphomes de type T

03/12/2018 - 20:46

CONGRÈS ANNUEL DE LA SOCIÉTÉ AMERICAINE D'HÉMATOLOGIE (ASH) 2018 : PRÉSENTATION DE NOUVEAUX RÉSULTATS D'IPH4102 CHEZ LES PATIENTS PRÉSENTANT UN SYNDROME DE SÉZARY RÉFRACTAIRE ET POURSUITE DU DÉVELOPPEMENT EN PHASE II [...]

BeiGene Presents Clinical Results of Tislelizumab in Relapsed/Refractory Classical Hodgkin’s Lymphoma at the 60th American Society of Hematology Annual Meeting

03/12/2018 - 20:15

Company to Host Investor Meeting and Webcast Today, December 3, at 8 pm PST BEIJING, China and CAMBRIDGE, Mass., Dec. 03, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE; HKEX: 06160), a commercial-stage [...]

Hybrigenics (ALHYG) : Moonstone Investments a soumis une proposition de transaction, sous conditions suspensives.

03/12/2018 - 20:12

C ette proposition, crédible et créatrice de valeur, vise à donner un nouvel espoir à la société Hybrigenics et ses actionnaires et constitue une alternative à la dissolution anticipée. Amsterdam, le 3 décembre 2018 Le [...]

CAPS® Teams with Kit Check to Add Serialized Radio Frequency Identification (RFID) Tags on Pre-Filled Syringes

03/12/2018 - 19:08

BETHLEHEM, Pa., Dec. 03, 2018 (GLOBE NEWSWIRE) -- Central Admixture Pharmacy Services, Inc. (CAPS) has announced a collaborative agreement to embed Kit Check’s serialized RFID tags on CAPS’ pre-filled anesthesia [...]

Exeter Hospital joins North American Partners in Anesthesia

03/12/2018 - 19:02

MELVILLE, N.Y., Dec. 03, 2018 (GLOBE NEWSWIRE) -- North American Partners in Anesthesia (NAPA) , one of the leading single-specialty anesthesia and perioperative management companies in the US, recently expanded [...]

Apellis Pharmaceuticals Presents New Data from Ongoing APL-2 Phase 2 Study in Patients with Cold Agglutinin Disease and Warm Antibody Autoimmune Hemolytic Anemia at ASH

03/12/2018 - 19:01

- New data on APL-2 demonstrate improvements in hematological parameters in cold agglutinin disease (CAD) and warm antibody autoimmune hemolytic anemia (wAIHA) - CAD patients treated with APL-2 had an improvement in [...]

Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting

03/12/2018 - 18:30

Phase 2 Interim Data Evaluating the Combination of Pracinostat and Azacitidine in Patients with Myelodysplastic Syndrome Presented at the 2018 American Society of Hematology Annual Meeting LUGANO, Switzerland and San [...]

NICOX : Number of voting rights as of November 30. 2018

03/12/2018 - 17:46

Nicox SA Société anonyme with a registered capital of € 29,715,320 Head Office: DRAKKAR D 2405 route des Dolines 06560 Valbonne Sophia-Antipolis R.C.S. GRASSE 403.942.642 On December 3, 2018, MONTHLY PUBLICATION OF THE [...]